Cobra Biologics

#Biologics #Cell and gene therapy #Cobra Biologics #DNA

Swedish government and industry to boost product partnerships 

Flerie Invest led a syndicate of investors in the $52 million acquisition of Cobra Biologics, Charles River Laboratories’ DNA and protein manufacturing subsidiary in Sweden. The new entity, NorthX Biologics, will take over and expand the facility, which is equipped to provide GMP-grade plasmid DNA and technical protein manufacture at commercial scale.   Ibrahim Baylan,… Read More

#News #Trending News #Trends & Analysis

#Cobra Biologics #Covid-19 #Scancell Holdings #Vaccines

Cobra Biologics to manufacture plasmids for Phase I clinical trial COVID-19 vaccine

Cobra Biologics is to manufacture Scancell Holdings COVID-19 vaccine. The agreement covers Good Manufacturing Practice (GMP) production of plasmid DNA needed to generate the DNA vaccine, against SARS-CoV-2, for use in a Phase I clinical trial in 2021 (COVIDITY). The project is funded by an Innovate UK grant awarded to… Read More

#Covid-19 #News